نتایج جستجو برای: metalated flavopiridol

تعداد نتایج: 668  

2003
Jingrui Jiang Christian B. Matranga Dongpo Cai Vaughan M. Latham Xinxin Zhang April M. Lowell Fabio Martelli Geoffrey I. Shapiro

Transformed cells are selectively sensitized to apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol after their recruitment to S phase. During S phase, cyclin A-dependent kinase activity neutralizes E2F-1 allowing orderly S phase progression. Inhibition of cyclin A-dependent kinase by flavopiridol could cause inappropriately persistent E2F-1 activity during S phase traversal...

Journal: :Molecular cancer therapeutics 2004
Xin-Yan Pei Yun Dai Steven Grant

Interactions between the cyclin-dependent kinase inhibitor flavopiridol and the small-molecule Bcl-2 antagonist HA14-1 were examined in human multiple myeloma cells. Whereas individual treatment of U266 myeloma cells with 10 micromol/L HA14-1 or 100 nmol/L flavopiridol had little effect, exposure of cells to flavopiridol (6 hours) followed by HA14-1 (18 hours) resulted in a striking increase in...

Journal: :Blood 2004
Yun Dai Mohamed Rahmani Xin-Yan Pei Paul Dent Steven Grant

Interactions between the cyclin-dependent kinase (CDK) inhibitor flavopiridol and the proteasome inhibitor bortezomib were examined in Bcr/Abl(+) human leukemia cells. Coexposure of K562 or LAMA84 cells to subtoxic concentration of flavopiridol (150-200 nM) and bortezomib (5-8 nM) resulted in a synergistic increase in mitochondrial dysfunction and apoptosis. These events were associated with a ...

Journal: :Blood 2011
Judith E Karp B Douglas Smith Linda S Resar Jacqueline M Greer Amanda Blackford Ming Zhao Dwella Moton-Nelson Katrina Alino Mark J Levis Steven D Gore Biju Joseph Hetty Carraway Michael A McDevitt Lorena Bagain Karen Mackey Janet Briel L Austin Doyle John J Wright Michelle A Rudek

Flavopiridol is a protein bound, cytotoxic, cyclin-dependent kinase inhibitor. Flavopiridol given by 1-hour bolus at 50 mg/m(2) daily 3 times followed by cytosine arabinoside and mitoxantrone (FLAM) is active in adults with poor-risk acute leukemias. A pharmacologically derived "hybrid" schedule (30-minute bolus followed by 4-hour infusion) of flavopiridol was more effective than bolus administ...

Journal: :Molecular cancer therapeutics 2007
Roberto R Rosato Jorge A Almenara Sarah S Kolla Sonia C Maggio Stefanie Coe Maria S Giménez Paul Dent Steven Grant

The mechanism and functional significance of XIAP and Mcl-1 down-regulation in human leukemia cells exposed to the histone deacetylase inhibitor vorinostat and the cyclin-dependent kinase inhibitor flavopiridol was investigated. Combined exposure of U937 leukemia cells to marginally toxic concentrations of vorinostat and flavopiridol resulted in a marked increase in mitochondrial damage and apo...

Journal: :The Journal of antimicrobial chemotherapy 2003
Peter J Nelson Vivette D D'Agati Jean-Michel Gries Jose-Ramon Suarez Irwin H Gelman

Cumulative evidence suggests that human immunodeficiency virus-associated nephropathy (HIVAN), the third leading cause of end-stage renal disease in African-Americans, may respond to therapeutic strategies that interrupt HIV-1 expression in infected renal epithelium. We recently demonstrated that suppression of HIV-1 transcription in infected glomerular visceral epithelial cells by flavopiridol...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1998
D S Schrump W Matthews G A Chen A Mixon N K Altorki

Esophageal adenocarcinoma (SKGT-2, SKGT-4, and SKGT-5) and epidermoid carcinoma (HCE-4) cells containing variable retinoblastoma (Rb), cyclin D1, p16, and p53 expression patterns were exposed to the synthetic flavone, flavopiridol. The IC50 was approximately 100-150 nM for each of these cell lines. Exposure of esophageal carcinoma cells to 300 nM flavopiridol induced cell cycle arrest and apopt...

Journal: :International journal of oncology 2015
Stefan Brenner Juliane Riha Benedikt Giessrigl Theresia Thalhammer Michael Grusch Georg Krupitza Bruno Stieger Walter Jäger

The contribution of organic anion transporting polypeptides (OATPs) to the cellular uptake of flavopiridol was investigated in OATP1B1-, OATP1B3- and OATP2B1-expressing Chinese hamster ovary (CHO) cells. Uptake of flavopiridol into these cells showed typical Michaelis-Menten kinetics with much higher transport capacity for OATP1B3 compared to OATP1B1 and OATP2B1 (Vmax/Km, 33.9 vs. 8.84 and 2.41...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
G I Shapiro D A Koestner C B Matranga B J Rollins

Flavopiridol, a synthetic flavone that inhibits tumor growth in vitro and in vivo, is a potent cyclin-dependent kinase (cdk) inhibitor presently in clinical trials. In the present study, the effect of 100-500 nM flavopiridol on a panel of non-small cell lung cancer cell lines was examined. All express a wild-type retinoblastoma susceptibility protein and lack p16INK4A, and only A549 cells are k...

Journal: :Cell cycle 2004
Elizabeth W Newcomb Cristina Tamasdan Yolanda Entzminger Elizabeth Arena Tona Schnee Mimi Kim Diana Crisan Yevgeniy Lukyanov Douglas C Miller David Zagzag

The mechanism of action of many chemotherapeutic agents targets the cell cycle. Recently, we demonstrated cytotoxic and other anti-tumor effects of flavopiridol, the first synthetic cyclin dependent kinase (CDK) inhibitor to enter clinical trials, on the murine GL261 glioma cell line in vitro (Newcomb et al., Cell Cycle 2003; 2:243). Given that flavopiridol has demonstrated anti-tumor activity ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید